Coeptis Therapeutics Holdings Inc
COEP
Get informed when a big investor buys or sells
+ FollowMarket Cap$38.62M
Close$
$1.28
88.4% downside
Current Fair Value
88.4% downsideOvervalued by 88.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $38.62 Million |
|---|---|
| Enterprise Value | $23.12 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.81 |
| Beta | -0.43 |
| Outstanding Shares | 49,758,736 |
Return
| Return on Equity | -14.46% |
|---|---|
| Return on Assets | -14.24% |
| Return on Invested Capital | -16.74% |
Valuation & Multiples
| P/E Ratio | -2.05 |
|---|---|
| PEG | -0.71 |
| Price to Sales | - |
| Price to Book Ratio | 5.5 |
| Enterprise Value to Revenue | 8.27 |
| Enterprise Value to EBIT | -1.04 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.12%▼ 0.05% |
|---|---|
| Total Invested | $78,540▼ 21.26% |
| Investors Holding | 10% |
ESG Score
No data
About Coeptis Therapeutics Holdings Inc
5 employees